TARGETED MOLECULAR IMMUNOTHERAPY Trademark

Trademark Overview

On Thursday, March 11, 2004, a trademark application was filed for TARGETED MOLECULAR IMMUNOTHERAPY with the United States Patent and Trademark Office. The USPTO has given the TARGETED MOLECULAR IMMUNOTHERAPY trademark a serial number of 78382707. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, June 30, 2015. This trademark is owned by Globeimmune, Inc.. The TARGETED MOLECULAR IMMUNOTHERAPY trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER AND INFECTIOUS DISEASE; THERAPEUTIC AND PROPHYLACTIC VACCINES
targeted molecular immunotherapy

General Information

Serial Number78382707
Word MarkTARGETED MOLECULAR IMMUNOTHERAPY
Filing DateThursday, March 11, 2004
Status800 - REGISTERED AND RENEWED
Status DateTuesday, June 30, 2015
Registration Number2968947
Registration DateTuesday, July 12, 2005
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Certificate of Correction for RegistrationIn the statement, Column 1, line 1, " Colorado" should be deleted, and Delaware should be inserted.
Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER AND INFECTIOUS DISEASE; THERAPEUTIC AND PROPHYLACTIC VACCINES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 28, 2005
Primary Code005
First Use Anywhere DateWednesday, February 9, 2005
First Use In Commerce DateWednesday, February 9, 2005

Trademark Owner History

Party NameGlobeimmune, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLouisville, CO 80027
Party NameGlobeimmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAurora, CO 80010

Trademark Events

Event DateEvent Description
Monday, September 27, 2004NON-FINAL ACTION MAILED
Friday, March 26, 2004NEW APPLICATION ENTERED
Friday, September 24, 2004ASSIGNED TO EXAMINER
Saturday, September 25, 2004NON-FINAL ACTION WRITTEN
Tuesday, April 19, 2005APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, April 25, 2005ASSIGNED TO LIE
Monday, March 21, 2005TEAS AMENDMENT OF USE RECEIVED
Monday, March 21, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 21, 2005USE AMENDMENT FILED
Tuesday, March 29, 2005AMENDMENT TO USE PROCESSING COMPLETE
Monday, March 21, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 29, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 19, 2005USE AMENDMENT ACCEPTED
Tuesday, April 19, 2005EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 19, 2005EXAMINERS AMENDMENT E-MAILED
Tuesday, July 12, 2005REGISTERED-SUPPLEMENTAL REGISTER
Monday, August 1, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 17, 2011CORRECTION UNDER SECTION 7 - PROCESSED
Thursday, April 28, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 9, 2006TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 9, 2006APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 6, 2011TEAS SECTION 8 RECEIVED
Monday, August 1, 2011POST REGISTRATION ACTION MAILED - SEC. 8
Wednesday, August 10, 2011TEAS SECTION 7 REQUEST RECEIVED
Tuesday, June 30, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 12, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 30, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, September 21, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, September 21, 2011NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, June 9, 2015TEAS SECTION 8 & 9 RECEIVED
Tuesday, June 30, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, June 30, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Related Keywords

immunotherapy molecular targeted therapeutic prophylactic vaccines disease infectious preparations treatment cancer pharmaceutical